Previous 10 | Next 10 |
-- Zai Lab obtains exclusive rights to develop and commercialize BLU-945 and BLU-701 in Greater China -- -- Collaboration accelerates and expands global development of Blueprint Medicines’ next-generation EGFR inhibitors with plans to bring clinical trials of BLU-945 and BL...
Tango Therapeutics (NASDAQ:TNGX) has appointed Marc Rudoltz as the company’s new Chief Medical Officer. An alumnus of the Massachusetts Institute of Technology (MIT) and SUNY-Upstate Medical University, Rudoltz has over 20 years of experience in leading clinical-stage drug develop...
Image source: The Motley Fool. Blueprint Medicines Corp (NASDAQ: BPMC) Q3 2021 Earnings Call Oct 28, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Blueprint Medicines Corp (BPMC) Q3 2021 Earnings Call Transcript ...
Blueprint Medicines Corporation (BPMC) Q3 2021 Earnings Conference Call October 28, 2021 8:30 a.m. ET Company Participants Jeff Albers - CEO Mike Landsittel - CFO Christy Rossi - CCO Fouad Namouni - President, R&D Becker Hewes - CMO Kristin Hodous - IR Conference Call Participants Andrea ...
Blueprint Medicines (NASDAQ:BPMC): Q3 GAAP EPS of -$2.00 misses by $0.37. Revenue of $24.19M (-96.8% Y/Y) misses by $18.39M. Guidance: The company expects to report full year 2021 total revenues in the range of $170-$180 million vs. consensus of $145.79 million. Press Release For furt...
Blueprint Medicines Reports Third Quarter 2021 Financial Results -- Strong AYVAKIT launch in advanced SM with $17.3 million in net product revenues in the first full quarter following U.S. approval -- -- Raising guidance for 2021 total revenue to $170-$180 million, based on ...
Blueprint Medicines to Report Third Quarter 2021 Financial Results on Thursday, October 28, 2021 PR Newswire CAMBRIDGE, Mass. , Oct. 21, 2021 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), today announced that it will host a live conference call ...
Lone Pine Capital’s 13F portfolio value increased from $27.53B to $31.66B. The number of positions decreased from 38 to 36. They added Moderna, RH, and Twitter and increased Square and ServiceNow. Also, they dropped Mercadolibre, Netflix, Atlassian, Bilibili, and Snowflake. ...
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IDNA. A list of cheap stocks. For further details see: IDNA: Healthcare Dashboard For September
Blueprint Medicines to Present at Morgan Stanley 19th Annual Global Healthcare Conference PR Newswire CAMBRIDGE, Mass. , Sept. 2, 2021 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that Kate Haviland , Blueprint Medici...
News, Short Squeeze, Breakout and More Instantly...
Blueprint Medicines Corporation Company Name:
BPMC Stock Symbol:
NASDAQ Market:
Blueprint Medicines Corporation Website:
Blueprint Medicines to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024 PR Newswire CAMBRIDGE, Mass. , July 18, 2024 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that it will host a live conference call an...
2024-07-10 04:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 12.5% to $0.27 on volume of 477,193,667 shares NVIDIA Corporation (NVDA) rose 1.9% to $128.2 on volume of 232,119,115 shares Virpax Pharmaceuticals Inc. (VRPX) rose 92.0% to $1.11 on volume o...